2013 annual financial data

Tempest Therapeutics, Inc. 2013 Operating margin

Tempest Therapeutics, Inc. 2013 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -29,134,000 USD and net income was -29,044,000 USD.
Operating cash flow was -18,094,000 USD.

Get free Tempest Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-29,134,000 USD
Net income
-29,044,000 USD
Operating cash flow
-18,094,000 USD